(19)
(11) EP 4 359 528 A1

(12)

(43) Date of publication:
01.05.2024 Bulletin 2024/18

(21) Application number: 22738426.0

(22) Date of filing: 27.06.2022
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 2320/31; C12N 2310/14; C12N 15/1131; C12N 2330/31
(86) International application number:
PCT/EP2022/067506
(87) International publication number:
WO 2022/269097 (29.12.2022 Gazette 2022/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.06.2021 EP 21181809

(71) Applicant: Alpine Antiviral GmbH
82152 Planegg (DE)

(72) Inventors:
  • HANNUS, Michael
    01099 Dresden (DE)
  • FINKE, Stefan
    17493 Greifswald - Insel Riems (DE)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) SIRNA COMBINATIONS TARGETING SARS-COV-2 AND/OR HOST FACTOR TRANSCRIPTS